The production of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, requires a complex complicated synthetic process. Preliminary routes focused on peptide portion coupling, utilizing solid-phase synthesis methodologies to build the long peptide sequence. Subsequent research has explored different approaches, including enz